BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20870635)

  • 1. The economic impact of non-melanoma skin cancer: a review.
    Mudigonda T; Pearce DJ; Yentzer BA; Williford P; Feldman SR
    J Natl Compr Canc Netw; 2010 Aug; 8(8):888-96. PubMed ID: 20870635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of Mohs micrographic surgery: review of the literature.
    Tierney EP; Hanke CW
    J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
    Rogers HW; Coldiron BM
    J Am Acad Dermatol; 2009 Jul; 61(1):96-103. PubMed ID: 19539843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mohs micrographic surgery: a cost analysis.
    Cook J; Zitelli JA
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
    Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
    Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of nonmelanoma skin cancer treatment in the United States.
    Chen JG; Fleischer AB; Smith ED; Kancler C; Goldman ND; Williford PM; Feldman SR
    Dermatol Surg; 2001 Dec; 27(12):1035-8. PubMed ID: 11849266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment patterns and cost of nonmelanoma skin cancer management.
    John Chen G; Yelverton CB; Polisetty SS; Housman TS; Williford PM; Teuschler HV; Feldman SR
    Dermatol Surg; 2006 Oct; 32(10):1266-71. PubMed ID: 17034377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of nonmelanoma skin cancer in the Medicare population.
    Manternach T; Housman TS; Williford PM; Teuschler H; Fleischer AB; Feldman SR; Chen GJ
    Dermatol Surg; 2003 Dec; 29(12):1167-9; discussion 1169. PubMed ID: 14725656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of skin cancer treatment and costs in the United States Medicare population, 1996-2008.
    Rogers HW; Coldiron BM
    Dermatol Surg; 2013 Jan; 39(1 Pt 1):35-42. PubMed ID: 23199014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost per episode of care in the surgical treatment of skin cancer].
    Hernández Martín A; Núñez Reiz A; Sáiz Martínez M; Rovirosa i Juncosa J
    Gac Sanit; 2006; 20(4):273-9. PubMed ID: 16942713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-melanoma skin cancer in Australia.
    Fransen M; Karahalios A; Sharma N; English DR; Giles GG; Sinclair RD
    Med J Aust; 2012 Nov; 197(10):565-8. PubMed ID: 23163687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the health care costs of non-melanoma skin cancer in Saskatchewan using physician billing data.
    Tran DA; Coronado AC; Sarker S; Alvi R
    Curr Oncol; 2019 Apr; 26(2):114-118. PubMed ID: 31043813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician specialty cost differences of treating nonmelanoma skin cancer.
    Chirikov VV; Stuart B; Zuckerman IH; Christy MR
    Ann Plast Surg; 2015 Jan; 74(1):93-9. PubMed ID: 24503881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health economic evaluation of non-melanoma skin cancer and actinic keratosis.
    Higashi MK; Veenstra DL; Langley PC
    Pharmacoeconomics; 2004; 22(2):83-94. PubMed ID: 14731050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis: Mohs micrographic surgery.
    Ravitskiy L; Brodland DG; Zitelli JA
    Dermatol Surg; 2012 Apr; 38(4):585-94. PubMed ID: 22443180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmelanoma skin cancer: an episode of care management approach.
    Housman TS; Williford PM; Feldman SR; Teuschler HV; Fleischer AB; Goldman ND; Balkrishnan R; Chen GJ
    Dermatol Surg; 2003 Jul; 29(7):700-11. PubMed ID: 12828693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin cancer is among the most costly of all cancers to treat for the Medicare population.
    Housman TS; Feldman SR; Williford PM; Fleischer AB; Goldman ND; Acostamadiedo JM; Chen GJ
    J Am Acad Dermatol; 2003 Mar; 48(3):425-9. PubMed ID: 12637924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Inflammation in Frozen Sections With Site of Nonmelanoma Skin Cancer.
    Alam M; Khan M; Veledar E; Pongprutthipan M; Flores A; Dubina M; Nodzenski M; Yoo SS
    JAMA Dermatol; 2016 Feb; 152(2):173-6. PubMed ID: 26579703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: an analysis of cost-effectiveness.
    Seidler AM; Bramlette TB; Washington CV; Szeto H; Chen SC
    Dermatol Surg; 2009 Nov; 35(11):1776-87. PubMed ID: 19737291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
    Bahner JD; Bordeaux JS
    Clin Dermatol; 2013; 31(6):792-8. PubMed ID: 24160289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.